<p>HM. BALB/c mice were fed with HM (0.25 or 0.5 mg/kg) or ACV (5 mg/kg) and after 8 h of drug treatment the animals were infected with HSV-2G (9 X 10<sup>5</sup> pfu per animal) intravaginally. The challenged animals of test groups were fed with HM twice daily for 7 days. Development of lesions and death were observed three times daily, while brain and vaginal tissue were collected after sacrification on days 2, 4, 6 or 8 after infection, homogenized and centrifuged. The supernatant was used for the determination of virus yield by plaque assay. Mean lesion score [A], Mean±S.D. of virus yield at log<sub>10</sub> (PFU/organ) in vaginal tissue [B] and brain [C]. </p
<p>(<b>A</b>) SCID mice were treated with a 500 µg dose of human anti-H3 hV26 and anti-B5 h101 retro...
<p>A) Depo-treated (vaginal) or untreated (anorectal) Balb/C mice were challenged with 10<sup>6</sup...
<p>A) HSV-2 enhancement model. Balb/C mice (n = 40 per group) were depo-treated 7 d before starting ...
<p>8 weeks old WT mice were infected intra-vaginally with 6.7×10<sup>4</sup> PFUs HSV-2. mIL-21 trea...
<p>Ten mice/group were inoculated intravaginally with 10<sup>3</sup> pfu/mouse of HSV1-LacZ, HSV1-Ta...
<p>: uninfected [A], infected with HSV-2G [B], HSV-2G infected animals treated with 0.5 µg/ml of HM ...
<p>Groups of mice (n = 10) were infected by the intravaginal route with a single dose (ranging from ...
<p>Mice were challenged with ∼10<sup>3</sup>, 10<sup>4</sup> or 10<sup>5</sup> pfu/mouse of HSV-2(46...
<p>Groups of mice were infected intracranially (A, B) or intraperitoneally (C) with the indicated do...
(b,c) Seven-week old female BALB/c mice were infected with 1.0 x 106 PFU HMPV clinical isolates or c...
<p>Groups of five female nu-nu mice were inoculated with HSV-2 on the lumbosacral area. Each group w...
<p>Mice were intranasally (IN) inoculated with Vero cell lysate (vehicle) or HSV-1 (10<sup>2</sup> P...
(A-C) Efficacy of virus inoculation. (A) Western blot showing the presence of ICP4 in trigeminal gan...
(a, b) Seven-week old female B6 mice were infected with 1.0 x 106 PFU HMPV clinical isolates or LLC-...
<p>Transgenic mice were infected intranasally with MERS-CoV and monitored for 12 days. (A) Body weig...
<p>(<b>A</b>) SCID mice were treated with a 500 µg dose of human anti-H3 hV26 and anti-B5 h101 retro...
<p>A) Depo-treated (vaginal) or untreated (anorectal) Balb/C mice were challenged with 10<sup>6</sup...
<p>A) HSV-2 enhancement model. Balb/C mice (n = 40 per group) were depo-treated 7 d before starting ...
<p>8 weeks old WT mice were infected intra-vaginally with 6.7×10<sup>4</sup> PFUs HSV-2. mIL-21 trea...
<p>Ten mice/group were inoculated intravaginally with 10<sup>3</sup> pfu/mouse of HSV1-LacZ, HSV1-Ta...
<p>: uninfected [A], infected with HSV-2G [B], HSV-2G infected animals treated with 0.5 µg/ml of HM ...
<p>Groups of mice (n = 10) were infected by the intravaginal route with a single dose (ranging from ...
<p>Mice were challenged with ∼10<sup>3</sup>, 10<sup>4</sup> or 10<sup>5</sup> pfu/mouse of HSV-2(46...
<p>Groups of mice were infected intracranially (A, B) or intraperitoneally (C) with the indicated do...
(b,c) Seven-week old female BALB/c mice were infected with 1.0 x 106 PFU HMPV clinical isolates or c...
<p>Groups of five female nu-nu mice were inoculated with HSV-2 on the lumbosacral area. Each group w...
<p>Mice were intranasally (IN) inoculated with Vero cell lysate (vehicle) or HSV-1 (10<sup>2</sup> P...
(A-C) Efficacy of virus inoculation. (A) Western blot showing the presence of ICP4 in trigeminal gan...
(a, b) Seven-week old female B6 mice were infected with 1.0 x 106 PFU HMPV clinical isolates or LLC-...
<p>Transgenic mice were infected intranasally with MERS-CoV and monitored for 12 days. (A) Body weig...
<p>(<b>A</b>) SCID mice were treated with a 500 µg dose of human anti-H3 hV26 and anti-B5 h101 retro...
<p>A) Depo-treated (vaginal) or untreated (anorectal) Balb/C mice were challenged with 10<sup>6</sup...
<p>A) HSV-2 enhancement model. Balb/C mice (n = 40 per group) were depo-treated 7 d before starting ...